First human tests begin for new drug compounds
NCT ID NCT07260851
Summary
This early-stage study aims to understand how the body processes and tolerates three new drug compounds (DWJ1622, DWC202313, and DWC202314). It will enroll 40 healthy adult volunteers to measure drug levels in the blood and check for side effects. The main goal is to gather basic safety and absorption data, not to treat any disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
H Plus YANGJI Hospital
RECRUITINGSeoul, Gwanak-gu, 08779, South Korea
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.